305 related articles for article (PubMed ID: 28669865)
1. Molecular signatures in breast cancer.
Lal S; McCart Reed AE; de Luca XM; Simpson PT
Methods; 2017 Dec; 131():135-146. PubMed ID: 28669865
[TBL] [Abstract][Full Text] [Related]
2. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
[TBL] [Abstract][Full Text] [Related]
3. A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.
Hachim IY; Shams A; Lebrun JJ; Ali S
Hum Pathol; 2016 Jul; 53():142-52. PubMed ID: 26980025
[TBL] [Abstract][Full Text] [Related]
4. [Gene signatures for breast cancer, clinical utility and therapeutic applications].
Vargas-Aguilar VM; Arroyo-Alvarez K
Rev Med Inst Mex Seguro Soc; 2018; 56(2):180-185. PubMed ID: 29906029
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of gene-expression signatures in early stage breast cancer.
Kwa M; Makris A; Esteva FJ
Nat Rev Clin Oncol; 2017 Oct; 14(10):595-610. PubMed ID: 28561071
[TBL] [Abstract][Full Text] [Related]
6. Prognostic stromal gene signatures in breast cancer.
Winslow S; Leandersson K; Edsjö A; Larsson C
Breast Cancer Res; 2015 Feb; 17(1):23. PubMed ID: 25848820
[TBL] [Abstract][Full Text] [Related]
7. CCR 20th Anniversary Commentary: Gene-Expression Signature in Breast Cancer--Where Did It Start and Where Are We Now?
Gingras I; Desmedt C; Ignatiadis M; Sotiriou C
Clin Cancer Res; 2015 Nov; 21(21):4743-6. PubMed ID: 26527804
[TBL] [Abstract][Full Text] [Related]
8. Genes and functions from breast cancer signatures.
Huang S; Murphy L; Xu W
BMC Cancer; 2018 Apr; 18(1):473. PubMed ID: 29699511
[TBL] [Abstract][Full Text] [Related]
9. Extensive Transcriptomic and Genomic Analysis Provides New Insights about Luminal Breast Cancers.
Tishchenko I; Milioli HH; Riveros C; Moscato P
PLoS One; 2016; 11(6):e0158259. PubMed ID: 27341628
[TBL] [Abstract][Full Text] [Related]
10. Correlating transcriptional networks with pathological complete response following neoadjuvant chemotherapy for breast cancer.
Liu R; Lv QL; Yu J; Hu L; Zhang LH; Cheng Y; Zhou HH
Breast Cancer Res Treat; 2015 Jun; 151(3):607-18. PubMed ID: 25981901
[TBL] [Abstract][Full Text] [Related]
11. Multigene prognostic tests in breast cancer: past, present, future.
Győrffy B; Hatzis C; Sanft T; Hofstatter E; Aktas B; Pusztai L
Breast Cancer Res; 2015 Jan; 17(1):11. PubMed ID: 25848861
[TBL] [Abstract][Full Text] [Related]
12. Relative Prognostic and Predictive Value of Gene Signature and Histologic Grade in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
Iwamoto T; Kelly C; Mizoo T; Nogami T; Motoki T; Shien T; Taira N; Hayashi N; Niikura N; Fujiwara T; Doihara H; Matsuoka J
Clin Breast Cancer; 2016 Apr; 16(2):95-100.e1. PubMed ID: 26631838
[TBL] [Abstract][Full Text] [Related]
13. The molecular basis of breast cancer pathological phenotypes.
Heng YJ; Lester SC; Tse GM; Factor RE; Allison KH; Collins LC; Chen YY; Jensen KC; Johnson NB; Jeong JC; Punjabi R; Shin SJ; Singh K; Krings G; Eberhard DA; Tan PH; Korski K; Waldman FM; Gutman DA; Sanders M; Reis-Filho JS; Flanagan SR; Gendoo DM; Chen GM; Haibe-Kains B; Ciriello G; Hoadley KA; Perou CM; Beck AH
J Pathol; 2017 Feb; 241(3):375-391. PubMed ID: 27861902
[TBL] [Abstract][Full Text] [Related]
14. Identification of Gene-Expression Signatures and Protein Markers for Breast Cancer Grading and Staging.
Yao F; Zhang C; Du W; Liu C; Xu Y
PLoS One; 2015; 10(9):e0138213. PubMed ID: 26375396
[TBL] [Abstract][Full Text] [Related]
15. Mammaprint™: a comprehensive review.
Brandão M; Pondé N; Piccart-Gebhart M
Future Oncol; 2019 Jan; 15(2):207-224. PubMed ID: 30156427
[TBL] [Abstract][Full Text] [Related]
16. Estimating the OncotypeDX score: validation of an inexpensive estimation tool.
Eaton AA; Pesce CE; Murphy JO; Stempel MM; Patil SM; Brogi E; Hudis CA; El-Tamer M
Breast Cancer Res Treat; 2017 Feb; 161(3):435-441. PubMed ID: 27928699
[TBL] [Abstract][Full Text] [Related]
17. MammaPrint and BluePrint comprehensively capture the cancer hallmarks in early-stage breast cancer patients.
Haan JC; Bhaskaran R; Ellappalayam A; Bijl Y; Griffioen CJ; Lujinovic E; Audeh WM; Penault-Llorca F; Mittempergher L; Glas AM
Genes Chromosomes Cancer; 2022 Mar; 61(3):148-160. PubMed ID: 34841595
[TBL] [Abstract][Full Text] [Related]
18. The prognostic potential of alternative transcript isoforms across human tumors.
Trincado JL; Sebestyén E; Pagés A; Eyras E
Genome Med; 2016 Aug; 8(1):85. PubMed ID: 27535130
[TBL] [Abstract][Full Text] [Related]
19. Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).
Bueno-de-Mesquita JM; van Harten WH; Retel VP; van 't Veer LJ; van Dam FS; Karsenberg K; Douma KF; van Tinteren H; Peterse JL; Wesseling J; Wu TS; Atsma D; Rutgers EJ; Brink G; Floore AN; Glas AM; Roumen RM; Bellot FE; van Krimpen C; Rodenhuis S; van de Vijver MJ; Linn SC
Lancet Oncol; 2007 Dec; 8(12):1079-1087. PubMed ID: 18042430
[TBL] [Abstract][Full Text] [Related]
20. Systematic review of the clinical and economic value of gene expression profiles for invasive early breast cancer available in Europe.
Blok EJ; Bastiaannet E; van den Hout WB; Liefers GJ; Smit VTHBM; Kroep JR; van de Velde CJH
Cancer Treat Rev; 2018 Jan; 62():74-90. PubMed ID: 29175678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]